Sunho Biologics (HKG:2898) said Yin Liusong stepped down as the company's chief executive and chief scientific officer to pursue opportunities elsewhere, according to a Hong Kong bourse filing Monday.
Shares of the biologics firm fell nearly 1% in morning trade Tuesday.
Yin's last working day will be Feb. 28.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments